Modified hydrolysis kinetics of the active lactone moiety of 10-hydroxycamptothecin by liposomal encapsulation

By Shi Kai   Tian Ye   Jiang Yanbo   Wang Lan   Cui Fude  

Pharmaceutical Development and Technology, Vol. 15, Iss. 6, 2010-12 ,pp. : 644-652

Informa Healthcare

Access to resources Recommend Favorite

Pharmacology of Topoisomerase I Inhibitors Irinotecan (CPT-11) and Topotecan

By  

Current Cancer Drug Targets, Vol. 2, Iss. 2, 2002-06 ,pp. : 103-123

Bentham Science Publishers

Access to resources Recommend Favorite

A phase I trial of irinotecan (CPT-11) with amifostine in patients with metastatic colorectal cancer

By Wakelee Heather   Fisher George  

Investigational New Drugs, Vol. 23, Iss. 3, 2005-06 ,pp. : 241-242

Springer Publishing Company

Access to resources Recommend Favorite

Activity of weekly irinotecan (CPT-11) in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes

By Sánchez Rosa   Esteban Emilio   Palacio Isabel   Fernández Yolanda   Muñiz Isabel   Vieitez Jose M.   Fra Joaquin   Blay Pilar   Villanueva Noemí   Uña Esther   Mareque Beatriz   Estrada Enrique   Buesa Jose M.   Lacave Angel J.  

Investigational New Drugs, Vol. 21, Iss. 4, 2003-11 ,pp. : 459-463

Springer Publishing Company

Access to resources Recommend Favorite

Population pharmacokinetics of PEGylated liposomal CPT-11 (IHL-305) in patients with advanced solid tumors

By Wu Huali   Infante Jeffrey   Keedy Vicki   Jones Suzanne   Chan Emily   Bendell Johanna   Lee Wooin   Zamboni Beth   Ikeda Satoshi   Kodaira Hiroshi   Rothenberg Mace   Burris Howard   Zamboni William  

European Journal of Clinical Pharmacology, Vol. 69, Iss. 12, 2013-12 ,pp. : 2073-2081

Springer Publishing Company

Access to resources Recommend Favorite